A 66-year-old woman rheumatoid arthritis was treated with methotrexate and tocilizumab. Chest radiography revealed bilateral consolidation of an upper lesion in the lung. Laboratory data indicated a hepatic disorder and increased eosinophils. Transbronchial lung biopsy specimens showed organizing pneumonia. Infection was unfavorable based on culture and PCR. Drug lymphocyte stimulation test showed positive results both for methotrexate and tocilizumab. We were concerned that her pneumonitis was drug-induced. And the symptoms appeared after the infusion of tocilizumab. Here, we report a case of tocilizumab-induced organizing pneumonia.ArticleINTERNAL MEDICINE. 50(19):2191-2193 (2011)journal articl
Abstract Background We report the case of a patient with rheumatoid arthritis (RA) treated with tofa...
BACKGROUND The management of (Coronavirus disease 2019) COVID-19 pneumonia is ever-evolving. Tociliz...
Abstract Background The development of pulmonary immune-related adverse events (irAEs) in patients u...
A 66-year-old woman rheumatoid arthritis was treated with methotrexate and tocilizumab. Chest radiog...
Pembrolizumab is a monoclonal antibody against the programmed cell death 1 (PD-1) receptor, and is w...
Until recently, chemotherapy for metastatic melanoma had disappointing results. The identification o...
Organizing pneumonia is defined histopathologically by intra-alveolar buds of granulation tissue, co...
Copyright © 2014 Kenji Yamagata et al.This is an open access article distributed under the Creative ...
13noThe SARS-COV-2-19-associated respiratory involvement is caused by the massive release of inflamm...
Osimertinib is the standard therapy for epidermal-growth-factor-receptor (EGFR)-mutant lung cancers....
International audienceTumour necrosis factor alpha inhibitors, both infliximab and adalimumab, have ...
Introduction Infliximab (Remicade, Centocor, Inc., Malvern, PA), a chimeric monoclonal antibody der...
A 67-year-old man presented to the hospital with complaints of fever and cough. He had a past medica...
International audienceWhen a patient treated by immune checkpoint inhibitors for metastatic melanoma...
peer reviewedA drug‐induced sarcoidosis‐like reaction is a systemic granulomatous reaction indisting...
Abstract Background We report the case of a patient with rheumatoid arthritis (RA) treated with tofa...
BACKGROUND The management of (Coronavirus disease 2019) COVID-19 pneumonia is ever-evolving. Tociliz...
Abstract Background The development of pulmonary immune-related adverse events (irAEs) in patients u...
A 66-year-old woman rheumatoid arthritis was treated with methotrexate and tocilizumab. Chest radiog...
Pembrolizumab is a monoclonal antibody against the programmed cell death 1 (PD-1) receptor, and is w...
Until recently, chemotherapy for metastatic melanoma had disappointing results. The identification o...
Organizing pneumonia is defined histopathologically by intra-alveolar buds of granulation tissue, co...
Copyright © 2014 Kenji Yamagata et al.This is an open access article distributed under the Creative ...
13noThe SARS-COV-2-19-associated respiratory involvement is caused by the massive release of inflamm...
Osimertinib is the standard therapy for epidermal-growth-factor-receptor (EGFR)-mutant lung cancers....
International audienceTumour necrosis factor alpha inhibitors, both infliximab and adalimumab, have ...
Introduction Infliximab (Remicade, Centocor, Inc., Malvern, PA), a chimeric monoclonal antibody der...
A 67-year-old man presented to the hospital with complaints of fever and cough. He had a past medica...
International audienceWhen a patient treated by immune checkpoint inhibitors for metastatic melanoma...
peer reviewedA drug‐induced sarcoidosis‐like reaction is a systemic granulomatous reaction indisting...
Abstract Background We report the case of a patient with rheumatoid arthritis (RA) treated with tofa...
BACKGROUND The management of (Coronavirus disease 2019) COVID-19 pneumonia is ever-evolving. Tociliz...
Abstract Background The development of pulmonary immune-related adverse events (irAEs) in patients u...